Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 11—November 2010
Research

Lymphotropism of Merkel Cell Polyomavirus Infection, Nova Scotia, Canada

Sonia Toracchio, Annette Foyle, Vojtech Sroller1, Jon A. Reed, Jun Wu, Claudia A. Kozinetz, and Janet S. ButelComments to Author 
Author affiliations: Baylor College of Medicine, Houston, Texas, USA (S. Toracchio, V. Sroller, J.A. Reed, C.A. Kozinez, J.S. Butel); Dalhousie University, Halifax, Nova Scotia, Canada (A. Foyle); Queen Elizabeth II Health Science Center, Halifax (A. Foyle); and Public Health Agency of Canada, Ottawa, Ontario, Canada (J. Wu); 1Current affiliation: Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Main Article

Table 3

MCPyV infection and characteristics of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, Nova Scotia, Canada, 1994–2001*

Characteristic No. (%) cases No. (%) MCPyV positive No. (%) MCPyV negative
Patient sex
M 16 (66.7) 2 (12.5) 14 (87.5)
F
8 (33.3)
3 (37.5)
5 (62.5)
Patient age, y
<60 6 (25.0) 0 6 (100.0)
>60
18 (75.0)
5 (27.8)
13 (72.2)
Disease stage†
I 9 (40.9) 1 (11.1) 8 (88.9)
II 5 (22.7) 3 (60.0) 2 (40.0)
III 0 0 0
IV
8 (36.4)
1 (12.5)
7 (87.5)
Patient survival‡
Alive in remission 2 (15.4) 1 (50.0) 1 (50.0)
Alive with disease 6 (46.1) 0 6 (100.0)
Dead from disease
5 (38.5)
1 (20.0)
4 (80.0)
Total 24 5 (20.8) 19 (79.2)

*No patients with chronic lymphocytic leukemia/small lymphocytic lymphoma had Merkel cell carcinoma. MCPyV, Merkel cell polyomavirus.
†Stage of disease for 2 MCPyV-negative patients was unknown.
‡Five-year follow-up survival information. Data were available for 13 patients, excluding 10 who had received a diagnosis within the past 5 y and one who was lost to follow-up. Disease refers to original diagnosis of either lymphoma or leukemia.

Main Article

Page created: March 08, 2011
Page updated: March 08, 2011
Page reviewed: March 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external